Official title and information are available only for Plus and Premium subscribers.
Patent Pending Imaging agents are chemicals designed to allow clinicians to determine whether a mass is benign or malignant and locate metastatic cancer sites in the body. The development of an imaging agent involves synthesizing the agent to target a particular tumor or process, after which the imaging instruments can be adjusted to neutralize the target.
To see the additional information details please login and subscribe to a Plus or Premium account.
